# InStockRx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/instockrx

- Industry: Software
- Headquarters: Palm Harbor, US
- Website: www.instockrx.com
- Total disclosed funding: $5M
- Latest round: Series A (Jun 30, 2026)
- Investors on record: 2

## About

InStockRx is a US-based pharmacy-to-pharmacy marketplace that facilitates the sale of surplus brand medications, enabling independent pharmacies to optimize inventory management and enhance cash flow.Founded in 2020 in Palm Harbor, US, InStockRx operates a marketplace that connects independent pharmacies, allowing them to buy and sell surplus medications. The company has raised USD 5 mn in Series A funding from FCA Venture Partners and Techstars, focusing on expanding its network and services for larger pharmacy operators. The founder's history and prior ventures are not publicly detailed.InStockRx operates a comprehensive pharmacy-to-pharmacy marketplace that enables independent pharmacies to list surplus medications, receive cash offers, and transact in a DSCSA-compliant manner. Features include T3 data for each transaction and invite-only Trading Partner Groups, promoting trusted networks for trading. The service addresses oversupply and expiration issues, helping pharmacies convert surplus stock into cash and achieve savings of up to 40% on brand medications.InStockRx generates revenue through transaction fees for buying and selling pharmaceuticals on its platform. Pharmacies receive offers from verified buyers, ensuring a quick and secure payment process upon shipment. The platform promotes direct B2B interactions among pharmacies, enhancing engagement with incentives for inviting other pharmacies to join.In June 2026, InStockRx successfully raised USD 5 mn in Series A funding to further develop its pharmacy-to-pharmacy marketplace, with a focus on expanding its network and serving larger pharmacy operations. The funding will be utilized to enhance its offerings and grow market presence, aimed at addressing the needs of a broader range of pharmacies.

## Funding rounds

- Series A, Jun 30, 2026, $5M — Techstars, FCA Venture Partners

## Investors

- Techstars (https://capitalatlas.ai/funds/techstars) — Series A
- FCA Venture Partners (https://capitalatlas.ai/funds/fca-venture-partners) — Series A